Results
633
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
633 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €731.60 | 5.4% | 130.8% | €31.8b | €746.20 | PE46.4x | E29.9% | 0.8% | Capital Goods | ||
ONON | US$60.15 | 3.7% | 129.1% | US$19.4b | US$61.85 | PE138.5x | E29.7% | n/a | Consumer Durables | ||
ARES | US$197.32 | 3.1% | 62.9% | US$61.3b | US$192.07 | PE92.1x | E38.4% | 1.9% | Diversified Financials | ||
NVDA | US$142.62 | 3.6% | 133.7% | US$3.6t | US$173.08 | PE55.4x | E24.5% | 0.03% | Semiconductors | ||
ALNY | US$278.76 | 13.2% | 55.2% | US$35.5b | US$299.71 | PS17.2x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
600760 | CN¥46.93 | -2.2% | 26.3% | CN¥129.3b | CN¥53.90 | PE52.6x | E29.4% | 0.9% | Capital Goods | ||
9992 | HK$91.50 | 4.5% | 393.5% | HK$121.4b | HK$96.02 | PE73.9x | E35.8% | 0.3% | Retail | ||
NU | US$12.34 | 7.0% | 29.9% | US$58.6b | US$15.06 | PB7.8x | E25.2% | n/a | Banks | ||
MRVL | US$124.02 | -0.6% | 82.3% | US$109.1b | US$127.72 | PS20x | E69.5% | 0.2% | Semiconductors | ||
300308 | CN¥128.25 | 9.7% | 54.8% | CN¥141.7b | CN¥197.44 | PE30.6x | E33.0% | 0.3% | Tech | ||
511243 | ₹1,223.15 | -2.8% | -1.5% | ₹1.0t | ₹1,509.06 | PE26.7x | E21.5% | 0.2% | Diversified Financials | ||
BESI | €135.90 | -7.6% | -4.8% | €10.8b | €146.00 | PE61x | E25.4% | 1.6% | Semiconductors | ||
2345 | NT$763.00 | 4.0% | 49.6% | NT$426.4b | NT$789.38 | PE43.8x | E25.1% | 1.3% | Tech | ||
300502 | CN¥134.49 | 12.6% | 158.6% | CN¥95.3b | CN¥161.36 | PE50x | E36.6% | 0.1% | Tech | ||
A196170 | ₩362,000.00 | 17.7% | 372.6% | ₩19.3t | ₩565,000.00 | PS259.4x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
BAM | CA$85.99 | 7.0% | 57.5% | CA$35.2b | CA$73.97 | PE55.9x | E87.6% | 2.5% | Diversified Financials | ||
ITCI | US$127.35 | 0.9% | 89.0% | US$13.5b | US$123.55 | PS22x | E52.2% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$94.74 | 2.0% | 4.5% | US$18.2b | US$132.07 | PE9.6x | E22.8% | 6.9% | Diversified Financials | ||
SMCI | US$33.27 | 7.9% | -29.8% | US$19.6b | US$40.79 | PE16.1x | E24.3% | n/a | Tech | ||
600989 | CN¥16.32 | -4.3% | 17.0% | CN¥119.7b | CN¥21.74 | PE19x | E38.5% | 1.7% | Materials | ||
PME | AU$272.03 | 9.4% | 171.8% | AU$28.4b | AU$215.10 | PE343.3x | E22.5% | 0.2% | Healthcare | ||
ISCTR | ₺14.50 | 1.5% | 43.3% | ₺415.8b | ₺18.40 | PB1.2x | E41.0% | 2.0% | Banks | ||
6669 | NT$2,240.00 | -7.2% | 7.7% | NT$416.3b | NT$3,007.76 | PE21.6x | E24.1% | 1.9% | Tech | ||
BAJFINANCE | ₹7,438.60 | 3.6% | 5.0% | ₹4.6t | ₹8,146.47 | PE29.9x | E22.7% | 0.5% | Diversified Financials |